SCHEMBL4187103

SCHEMBL4187103

FC(F)(F)c1cc(C(F)(F)F)c2nc(-c3ccc(-c4ccccn4)c4ccccc34)[nH]c2c1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CBFB Q13951 6/20 0.60
CACNA1H O95180 7/20 0.44
CACNA1G O43497 2/20 0.44
SYK P43405 2/20 0.44
CACNA1C Q13936 2/20 0.43
CACNA1B Q00975 1/20 0.43
KDM4E B2RXH2 1/20 0.43
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TP53 P04637 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
METAP2 P50579 1/20 0.40
PTGES O14684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15981090 0.88 CBFB (0.75) CBFBCACNA1HCACNA1GSYKCACNA1C
SCHEMBL13969149 0.86 CBFB (0.46) CBFBSYKKDM4ENPC1ALDH1A1
SCHEMBL4186727 0.85 CBFB (0.55) CBFBCACNA1HCACNA1GSYKCACNA1C
SCHEMBL4174460 0.84 CBFB (0.62) CBFBCACNA1HCACNA1GSYKCACNA1C
SCHEMBL4188959 0.83 CBFB (0.53) CBFBCACNA1HCACNA1GCACNA1CCACNA1B
SCHEMBL4189049 0.78 CBFB (0.47) CBFBCACNA1HCACNA1GCACNA1CCACNA1B
SCHEMBL4188519 0.78 CBFB (0.50) CBFBCACNA1HCACNA1GCACNA1CCACNA1B
SCHEMBL4182354 0.78 CBFB (0.42) CBFBCACNA1HCACNA1GCACNA1CCACNA1B
SCHEMBL15780001 0.76 CBFB (0.75) CBFBKDM4ENPC1ALDH1A1TP53
SCHEMBL15978513 0.75 CBFB (0.59) CBFBSYKKDM4ENPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090018124-A1 Novel Benzoimidazole Derivatives and Pharmaceutical Composition Comprising the Same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2009-01-15 US claimed
US-9199965-B2 Benzoimidazole derivatives and pharmaceutical composition comprising the same DAEWOONG CO., LTD. (KR) 2015-12-01 US disclosed
US-9199965-B2 Benzoimidazole derivatives and pharmaceutical composition comprising the same DAEWOONG CO., LTD. (KR) 2015-12-01 US disclosed
US-9199965-B2 Benzoimidazole derivatives and pharmaceutical composition comprising the same DAEWOONG CO., LTD. (KR) 2015-12-01 US disclosed
EP-1861387-B1 BENZIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF DAE WOONG PHARMA (KR) 2014-04-16 EP disclosed
EP-1861387-B1 BENZIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF DAE WOONG PHARMA (KR) 2014-04-16 EP disclosed
US-20090018124-A1 Novel Benzoimidazole Derivatives and Pharmaceutical Composition Comprising the Same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2009-01-15 US disclosed
US-20090018124-A1 Novel Benzoimidazole Derivatives and Pharmaceutical Composition Comprising the Same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2009-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018124-A1 Novel Benzoimidazole Derivatives and Pharmaceutical Composition Comprising the Same TRPV1, TRPA1, BDKRB2 CBFB 1891/4885CACNA1H 522/4885CACNA1G 368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.